VentriPoint Diagnostics Ltd.
VPTDF
$0.09
$0.00-2.95%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 25.27% | 83.71% | 258.56% | 92.54% | 277.74% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 25.27% | 83.71% | 258.56% | 92.54% | 277.74% |
| Cost of Revenue | -- | -- | -- | -- | -100.00% |
| Gross Profit | 25.27% | 102.93% | 321.91% | 123.40% | 481.98% |
| SG&A Expenses | -19.81% | -6.98% | -2.21% | -0.39% | 14.32% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -26.24% | -15.36% | -5.43% | -3.04% | 5.06% |
| Operating Income | 27.64% | 16.78% | 7.94% | 3.98% | -3.03% |
| Income Before Tax | 20.91% | 9.99% | 1.64% | -1.21% | -6.61% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 22.50% | 11.60% | 3.34% | 0.44% | -6.61% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 22.50% | 11.60% | 3.34% | 0.44% | -6.61% |
| EBIT | 27.64% | 16.78% | 7.94% | 3.98% | -3.03% |
| EBITDA | 27.63% | 16.73% | 7.87% | 3.91% | -3.12% |
| EPS Basic | 25.21% | 13.98% | 4.93% | 1.30% | -6.25% |
| Normalized Basic EPS | 22.30% | 11.56% | 2.88% | 0.00% | -5.71% |
| EPS Diluted | 25.21% | 13.98% | 4.93% | 1.30% | -6.25% |
| Normalized Diluted EPS | 22.30% | 11.56% | 2.88% | 0.00% | -5.71% |
| Average Basic Shares Outstanding | 4.24% | 2.78% | 1.68% | 0.87% | 0.17% |
| Average Diluted Shares Outstanding | 4.24% | 2.78% | 1.68% | 0.87% | 0.17% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |